Preferred Label : tagraxofusp;

CISMeF synonym : SL-401 fusion protein;

UNII : 8ZHS5657EH;

Details


Main resources

You can consult :


https://www.has-sante.fr/jcms/p_3281016/fr/elzonris-tagraxofusp
2021
false
false
false
France
treatment outcome
insurance, health, reimbursement
tagraxofusp
Elzonris
Product containing only tagraxofusp in parenteral dose form (medicinal product form)
infusions, intravenous
tagraxofusp
adult
Blastic Plasmacytoid Dendritic Cell Neoplasm
histiocytic disorders, malignant
antineoplastic agents
evaluation of the transparency committee

---
https://www.ema.europa.eu/en/medicines/human/EPAR/elzonris
2021
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
tagraxofusp
tagraxofusp
tagraxofusp
antineoplastic agents
antineoplastic agents
orphan drug production
adult
Blastic Plasmacytoid Dendritic Cell Neoplasm
infusions, intravenous
product surveillance, postmarketing
pregnancy
breast feeding
interleukin-3 receptor alpha subunit
drug evaluation, preclinical
recombinant fusion proteins
recombinant fusion proteins

---
Nous contacter.
27/04/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.